Cite
HARVARD Citation
de Boer, S. et al. (2018). Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet oncology. 19 (3), pp. 295-309. [Online].